J Caen

4.6k total citations
114 papers, 3.6k citations indexed

About

J Caen is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J Caen has authored 114 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 24 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in J Caen's work include Platelet Disorders and Treatments (63 papers), Blood properties and coagulation (21 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). J Caen is often cited by papers focused on Platelet Disorders and Treatments (63 papers), Blood properties and coagulation (21 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). J Caen collaborates with scholars based in France, China and United States. J Caen's co-authors include Zhongchao Han, Jean Bernard, P.A. Castaldi, Sylvia Bellucci, M J Larrieu, Claudine Soria, Mónica Alemany, Alan T. Nurden, Andréas Bikfalvi and S Inceman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

J Caen

109 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Caen France	34	1.9k	846	743	469	455	114	3.6k
John W. Forstrom United States	18	1.2k 0.6×	1.3k 1.5×	401 0.5×	417 0.9×	253 0.6×	23	3.5k
Jean‐Philippe Rosa France	28	1.4k 0.7×	824 1.0×	344 0.5×	249 0.5×	358 0.8×	64	2.7k
M Okuma Japan	25	866 0.5×	666 0.8×	420 0.6×	341 0.7×	405 0.9×	99	2.7k
Timothy J. Stalker United States	34	1.5k 0.8×	1.0k 1.2×	630 0.8×	195 0.4×	908 2.0×	73	3.7k
Judith M.E.M. Cosemans Netherlands	38	2.2k 1.2×	674 0.8×	691 0.9×	452 1.0×	1.0k 2.3×	73	3.6k
Marijke J. E. Kuijpers Netherlands	33	1.7k 0.9×	700 0.8×	588 0.8×	410 0.9×	789 1.7×	81	3.2k
M B Stemerman United States	31	470 0.2×	1.1k 1.3×	470 0.6×	180 0.4×	619 1.4×	52	3.3k
Daniel T. Eitzman United States	38	1.1k 0.6×	1.0k 1.2×	605 0.8×	335 0.7×	1.5k 3.4×	100	5.2k
Jerry S. Powell United States	33	1.6k 0.8×	1.4k 1.7×	311 0.4×	468 1.0×	1.1k 2.3×	85	4.3k
Varda Deutsch Israel	28	939 0.5×	922 1.1×	296 0.4×	467 1.0×	180 0.4×	84	2.6k

Countries citing papers authored by J Caen

Since Specialization

Citations

This map shows the geographic impact of J Caen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Caen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Caen more than expected).

Fields of papers citing papers by J Caen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Caen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Caen. The network helps show where J Caen may publish in the future.

Co-authorship network of co-authors of J Caen

This figure shows the co-authorship network connecting the top 25 collaborators of J Caen. A scholar is included among the top collaborators of J Caen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Caen. J Caen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, Jinsong, Kankan Wang, L. Dong, et al.. (2010). PML/RARα fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association. Proceedings of the National Academy of Sciences. 107(8). 3716–3721. 21 indexed citations

Li, Yanhan, et al.. (2003). Suppression of Tumor Growth by Viral Vector–Mediated Gene Transfer of N-Terminal Truncated Platelet Factor 4. Cancer Biotherapy and Radiopharmaceuticals. 18(5). 829–840. 16 indexed citations

Zhu, Jun, Lei Pan, Xun Cai, et al.. (1999). Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents. Leukemia. 13(7). 1062–1070. 55 indexed citations

Lü, Min, Jack Levin, Eric Sulpice, et al.. (1999). Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. Experimental Hematology. 27(5). 845–852. 65 indexed citations

Han, Zhongchao, Sylvia Bellucci, Zhixiang Shen, et al.. (1996). Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators. Journal of Cellular Physiology. 168(1). 97–104. 40 indexed citations

Amiral, Jean, et al.. (1996). Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell lines. Journal of Laboratory and Clinical Medicine. 127(2). 179–185. 3 indexed citations

Gu, Xue, et al.. (1995). Constitutive and selective expression of basic fibroblast growth factor in human leukaemia cell lines. European Journal Of Haematology. 55(3). 189–194. 14 indexed citations

Xi, Xueyan, et al.. (1995). [Platelet factor 4 acts as both inhibitor and protector of hematopoietic precursor cells: possible mechanism of action].. PubMed. 28(4). 415–26. 4 indexed citations

Djaffar, Isabelle, J Caen, & Jean‐Philippe Rosa. (1993). A large alteration in the human platelet glycoprotein Illa (integrin β₃) gene associated with Glanzmann's thrombasthenia. Human Molecular Genetics. 2(12). 2183–2185. 17 indexed citations

10.

Gris, Jean‐Christophe, et al.. (1992). Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant. American Journal of Hematology. 41(2). 92–96. 18 indexed citations

11.

Bellucci, Sylvia, Zhongchao Han, & J Caen. (1991). Studies of in vitro megakaryocytopoiesis in adult immune thrombocytopenic purpura (ITP). European Journal Of Haematology. 47(2). 86–90. 9 indexed citations

12.

Commin, P, et al.. (1990). A1205 MECHANISMS OF BLEEDING REDUCTION INDUCED BY APROTININ DURING CARDIOPULMONARY BYPASS: A CONTROLLED STUDY. Anesthesiology. 73(3A). NA–NA. 3 indexed citations

13.

Faivre, René, Eric Neuhart, Massoud Mirshahi, et al.. (1989). Fibrinolytic and Thrombolytic Parameters in Patients with Deep Vein Thrombosis Treated by Low Molecular Weight and Standard Heparin. Seminars in Thrombosis and Hemostasis. 15(4). 435–439. 5 indexed citations

14.

Mirshahi, Manouchehr, Claudine Soria, Jeannette Soria, et al.. (1988). Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosis. Thrombosis Research. 51(3). 295–302. 18 indexed citations

15.

Dosquet, Christine, et al.. (1988). Rapid evolution in the immunochemical findings of a gamma heavy chain disease.. Clinical Chemistry. 34(2). 439–443. 2 indexed citations

16.

Rendu, Francine, Pierre Marché, Jacques Viret, et al.. (1987). Signal transduction in normal and pathological thrombin-stimulated human platelets. Biochimie. 69(4). 305–313. 19 indexed citations

17.

Caen, J, S Cronberg, & Peter Kubisz. (1977). Platelets : physiology and pathology. 12 indexed citations

18.

Caen, J, et al.. (1972). Adenosine Inhibition of Human Platelet Aggregation by ADP. Nature New Biology. 239(94). 211–213. 4 indexed citations

19.

Caen, J. (1968). Thrombopathie et thrombasthénie.. Schweizerische medizinische Wochenschrift. 98(42). 3 indexed citations

20.

Inceman, S, J Caen, & Jean Bernard. (1966). Aggregation, adhesion, and viscous metamorphosis of platelets in congenital fibrinogen deficiencies.. PubMed. 68(1). 21–32. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact